Work

Ambulatory Blood Pressure Changes Following Initiation of Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease

Year: 2026
Type: article
Abstract: Background/Objectives: Cardiovascular autonomic dysfunction is common in advanced Parkinson’s disease (PD), but 24-h ambulatory blood pressure profiles after initiation of continuous subcutaneous foslevodopa/foscarbidopa have not been fully characterized. Methods: In this retrospective, single-center exploratory longitudinal study, 21 patients underwent ambulatory blood pressure monitoring at baseline, during the first week after maintenance-dose optimization, and at 1 and 6 months. Results: The prevalence of nocturnal hypertension differed across visits (90.5% at baseline; 68.4% at 6 months; global p = 0.033). Nighttime systolic and diastolic blood pressure were lower at 6 months, with significant global differences (p = 0.042 and p = 0.021), whereas daytime measures did not differ significantly. Significant global differences were found for 24-h systolic blood pressure standard deviation, coefficient of variation, and average real variability (p = 0.007, p = 0.037, and p = 0.010). Nocturnal exposure to mean arterial pressure > 100 mmHg decreased, whereas no statistically significant increases in exposure to mean arterial pressure < 65 mmHg or in the prevalence of orthostatic hypotension were detected. The prevalence of supine hypertension differed across visits (p = 0.048). Conclusions: Follow-up was characterized by lower nocturnal hypertensive burden and reduced systolic blood pressure variability, without a group-level signal of worsening orthostatic responses. Larger controlled studies are required to confirm these exploratory findings.
Source: Biomedicines
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236561784
FWCI:
Cites: 45
Cited by:
Related to: 10